
LYCA vs RXRX
$LYCA vs $RXRX head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
LYCA vs RXRX: the quick read
- ·RXRX is the larger company by market cap ($1.76B vs $1.63B).
- ·RXRX has been more active on our scanner (326 vs 157 alerts in 30 days).
- ·LYCA has the smaller float (47.9M vs 593.1M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (Biological Products, (No Diagnostic Substances) vs BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)), so they answer to different catalysts and a move in one says little about the other.
- ·They trade in different worlds by share price: RXRX is a low-priced stock where a few cents is a real percentage move, while the other is priced for steadier increments.
- ·Both stay busy on our scanner, 326 and 157 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are closely matched in size, within 8% of each other on market cap, which makes the rest of this table the interesting part.
- ·They have diverged badly over the year: LYCA is near the top of its 52-week range while RXRX is near the bottom of its own.
- ·They are pulling apart today: LYCA is outperforming the other by roughly 7.6 percentage points on the session.
Objective differences only. Not investment advice.
Watching LYCA or RXRX? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing LYCA and RXRX on TheDesperateTrader.
- Is LYCA or RXRX the better stock?
- "Better" depends on your goal, and these two are not alike. RXRX is the larger company by market cap ($1.76B vs $1.63B). RXRX has been more active on our scanner (326 vs 157 alerts in 30 days). LYCA has the smaller float (47.9M vs 593.1M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between LYCA and RXRX?
- The differences that matter: they are not in the same business - LYCA is biological products, (no diagnostic substances) and RXRX is biological products, (no diagnostic substances); they are similar in size ($1.63B vs $1.76B); they trade at very different share prices ($32.30 vs $2.69); LYCA sits at 87% of its 52-week range against 7% for RXRX; our scanner flagged LYCA 157 times in the last 30 days against 326 for RXRX. Everything above is measured from the latest completed session and SEC filings.
- Which of LYCA and RXRX is more active right now?
- Right now LYCA is at about 1.1x its normal volume and RXRX is at about 1.5x, so RXRX is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading LYCA or RXRX? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore LYCA and RXRX comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.